LGALS3 and cutaneous mastocytosis: Gal-3 has the potential to alter the pathogenic course of experimental cerebral malaria (CM) through its binding to the endogenous oligosaccharides on matrix proteins and its release after the lysis of brain-infiltrating macrophages.